Figure 5
From: Thapsigargin sensitizes human esophageal cancer to TRAIL-induced apoptosis via AMPK activation
Thapsigargin and TRAIL co-treatment repress the invasion in human ESCC cells (24 h).
Representative invasive capability images are shown. The invasive capability is expressed as an invasion rates. The number of invasive cells in the control group was set as 100%. The results are expressed as the mean ± SD; n = 6. aP < 0.05 vs. the control group in EC109 cells,abP < 0.05 vs. the control group in TE12 cells.
